Measuring lymph flow velocity in superficial lymph vessels using Transonic Transit Time Ultrasound Microvascular Flowprobe (AureFlo®), a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29245

Enrollment

Registered

2020-01-06

Start date

2020-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: age > 18 years, absence of clinical lymphedema, indication for free radial forearm flap and no earlier operations or scars in that extremity at the level of wrist or forearm.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria cannot participate in this study: a history of lymphedema of any etiology, axillary lymph node metastases and history of axillary lymph node dissection.

Design outcomes

Primary

Measure	Time frame
The main study endpoint is lymph flow velocity in the superficial lymphatic vessels in the wrist/forearm in ml/min.	—

Contacts

Public ContactRenée Miseré

MUMC

renee.misere@mumc.nl0612764404

Outcome results